A Study of AL102 in Patients With Progressing Desmoid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mrinal Gounder, MD
MSKCC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
53 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Adelaide Cancer Centre
Kurralta Park, South Australia, Australia
- Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
- Universitair Ziekenhuis
Ghent, Belgium
- Universitaire Ziekenhuizen Leuven
Leuven, Belgium
- Helios Klinikum Berlin-Buch
Berlin, Germany
- Mannheim University Medical Center
Mannheim, Germany
- Oncology Institute Barzilai Medical Center
Ashkelon, Israel
- Rambam Mc
Haifa, Israel
- Hadassah University Hospital - Ein Kerem
Jerusalem, Israel
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
- Irccs Istituto Ortopedico Rizzoli
Bologna, Italy
- Irccs Fondazione Istituto Nazionale Dei Tumori
Milan, Italy
- Campus Bio-Medico University Hospital
Rome, Italy
- the Netherlands Cancer Institute
Amsterdam, Netherlands
- Leiden University Medical Center
Leiden, Netherlands
- Erasmus Medisch Centrum
Rotterdam, Netherlands
- Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, Poland
- Asan Medical Center
Seoul, South Korea
- Severance Hospital, Yonsei University Health System
Seoul, South Korea
- Catalan Institute of Oncology (ico)
Barcelona, Spain
- Vall D´hebrón University Hospital
Barcelona, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario Fundacion Jimenez Diaz
Madrid, Spain
- Hospital Universitario Miguel Servet
Zaragoza, Spain
- Western General Hospital
Edinburgh, Scotland, United Kingdom
- Addenbrooke'S Hospital
Cambridge, United Kingdom
- the Royal Marsden Hospital
London, United Kingdom
- the Christie Nhs Foundation Trust
Manchester, United Kingdom
- Mayo Clinic
Pheonix, Arizona, United States
- City of Hope
Duarte, California, United States
- Sarcoma Oncology Research Center
Santa Monica, California, United States
- University of California at Los Angeles Hematology/oncology
Santa Monica, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Northshore University Health System
Evanston, Illinois, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Jefferson City Medical Group
Jefferson City, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Sept 2021
- Primary completion
- 3 Dec 2025
- Completion
- 31 Dec 2026
- Last update posted
- 8 Jun 2026
- Registered enrollment
- 198
- Registry id
- NCT04871282
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.